Alprolix Lyophilisate For Solution For Injection 1000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

ALPROLIX: Lyophilisate for solution for injection (1000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FACTOR IX Fc FUSION PROTEIN (fak tir nine Fc FYOO zhuh n PROH teen) is used in patients with hemophilia B to help prevent and control bleeding.

In-Depth Information

ALPROLIX 1000units Powder for Injection

NDC: 644060922
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Surgical Bleeding, Bleeding Prophylaxis, Hemorrhage, Hemophilia B

Storage Information
May be stored at temperatures up to 86 degrees F for up to 6 months
Protect from light
Store in original container
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
Product stored at controlled room temperature should not be returned to a refrigerator
Store between 36 to 46 degrees F
Reconstituted product should be used within 3 hours
ALPROLIX 1000units Powder for Injection

Reported Side Effects for ALPROLIX 1000units Powder for Injection

Lightheadedness Incidence:
0.8%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
0.8%*
Severity: MILD
Onset: EARLY
Bad Breath Incidence:
0.8%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
0.8%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
0.8%*
Severity: MODERATE
Onset: RAPID
Tired Incidence:
0.8%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
1.7%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with ALPROLIX

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5